CMS NCD 368 Modified: What the Gender Dysphoria and Gender Reassignment Surgery Policy Change Means for Your Practice
The Centers for Medicare & Medicaid Services (CMS) has issued a modification to National Coverage Determination (NCD) 368, governing coverage of gender reassignment surgery for Medicare beneficiaries diagnosed with gender dysphoria. As of March 12, 2026, this policy update reaffirms the existing framework established in August 2016—but the modification itself signals that CMS has conducted a fresh review of the determination, making this the right moment for billing teams to audit their current workflows and MAC-specific coverage guidance.
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Gender Dysphoria and Gender Reassignment Surgery |
| Policy Code | NCD 368 |
| Change Type | Modified |
| Effective Date | 2026-03-12 |
| Impact Level | High |
| Specialties Affected | Plastic surgery, urology, gynecology, endocrinology, psychiatry, primary care |
| Key Action | Contact your MAC immediately to confirm current local coverage determinations (LCDs) for gender reassignment surgery claims. |
What CMS NCD 368 Actually Says About Gender Reassignment Surgery Coverage
Under NCD 368, CMS has determined that no national coverage determination is appropriate for gender reassignment surgery for Medicare beneficiaries with gender dysphoria. That language is precise and consequential: CMS is not designating these procedures as covered, and it is not designating them as non-covered at the national level. The policy explicitly notes both the "Nationally Covered Indications" and "Nationally Non-Covered Indications" sections are listed as N/A.
What fills that vacuum is local decision-making. Coverage determinations fall to the individual Medicare Administrative Contractors (MACs) under Section 1862(a)(1)(A) of the Social Security Act. Each MAC evaluates claims on a case-by-case basis, applying its own local coverage determinations and medical necessity standards.
This decentralized structure has significant operational implications. A claim that gets paid in one MAC jurisdiction may be denied in another—and your billing team needs to know exactly which MAC covers your geographic region and what that MAC's current LCD says.
The 2016 Baseline — and Why the 2026 Modification Still Matters
The underlying policy dates to August 30, 2016, when CMS formally concluded its National Coverage Analysis on gender reassignment surgery. At that time, after examining the available medical evidence, CMS determined a national determination was not warranted. The policy was last reviewed in August 2016, which is the date noted in the policy document itself.
The March 2026 modification means CMS has formally updated this NCD in some capacity. Billing managers should not treat this as a rubber stamp of the status quo without verification. Policy modifications—even those that preserve existing coverage frameworks—can reflect updated clinical language, changes to the administrative process, or shifts in how medical necessity is evaluated at the local level.
If your practice bills for gender-affirming surgical procedures for Medicare patients, this is not a situation where you wait for a denial to find out what changed. Pull the updated policy documentation, contact your MAC, and compare current LCD guidance against what was in place prior to March 12, 2026.
How Medicare Coverage Is Actually Determined Under This NCD
Because NCD 368 defers to MACs, the practical coverage question for any given claim depends on the following:
Medical necessity under Section 1862(a)(1)(A) of the Social Security Act. Services must be reasonable and necessary for the diagnosis or treatment of illness or injury. For gender reassignment surgery, MACs apply this standard in the context of a gender dysphoria diagnosis. Documentation of the diagnosis, clinical history, and treatment pathway is essential.
MAC-specific LCD guidance. Each MAC may have published an LCD that outlines what documentation it requires, whether prior authorization or prior determination requests are accepted, and how it defines medical necessity for specific procedures in this category.
Case-by-case adjudication. Even where a MAC has published an LCD, individual claims are still subject to case-by-case review. This means clinical documentation—letters from treating mental health providers, history of gender-affirming care, surgical records—needs to be thorough and organized before a claim is submitted.
There are no nationally mandated prior authorization requirements under this NCD, but your MAC may impose its own. Check directly.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
Affected Codes
The policy document for NCD 368 does not list specific CPT, HCPCS, or ICD-10 codes. No codes appear in the current policy data.
This is itself a meaningful data point. The absence of enumerated codes reinforces the case-by-case, MAC-dependent nature of coverage under this NCD. Billing teams should not assume a specific CPT code is covered or excluded based on this NCD alone.
To identify the codes your MAC is adjudicating—and under what criteria—you need to review your MAC's current LCD directly. Common MAC jurisdictions include Novitas Solutions, CGS Administrators, WPS Government Health Administrators, First Coast Service Options, and Palmetto GBA, among others. CMS maintains a list of MACs by state at cms.gov.
What Your Billing Team Should Do
| # | Action Item |
|---|---|
| 1 | Identify your MAC and pull its current LCD within the next two weeks. Search the Medicare Coverage Database (coverage.cms.gov) for your MAC's LCD on gender reassignment surgery or gender dysphoria. Note the effective date and any documentation requirements specified. |
| 2 | Compare the pre- and post-March 12, 2026 NCD language. CMS has classified this as a modification, not a reaffirmation. Review the updated NCD 368 document against prior versions to identify any language changes that could affect how your MAC interprets medical necessity or adjudicates claims. |
| 3 | Audit claims submitted since January 1, 2026. If your practice has submitted claims for gender reassignment procedures under Medicare, verify that those claims align with your MAC's current LCD guidance. Flag any that may need additional documentation or reconsideration. |
| 4 | Update your documentation templates. Ensure your intake and clinical documentation process captures all elements your MAC requires for medical necessity: gender dysphoria diagnosis, duration of treatment, mental health provider letters, surgical consultation notes, and any hormone therapy history. |
| 5 | Submit a prior determination request if your MAC allows it. Some MACs accept voluntary prior determination requests for surgical procedures. This does not guarantee payment, but it reduces the risk of a post-service denial and gives your team documentation of the MAC's coverage position before the procedure occurs. |
| 6 | Brief your clinical team on what has changed. Physicians and clinical staff often don't know when a policy is modified. A brief internal memo summarizing the March 2026 NCD update—and the MAC review requirement—keeps everyone aligned and reduces documentation gaps that lead to denials. |
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.